Brind.
  1. FDA fast-tracking of a therapy involving Precision BioSciences, Arrowhead Pharmaceuticals, and Gilead Sciences began on July 1, 2025.

Arrowhead Pharmaceuticals issued a press release from its offices in Pasadena on June 23, 2025.

2 reports, 1 independent Updated Sep 6
Gone quiet
Reports
2
Developments
1
Repetition
50%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Arrowhead Pharmaceuticals issued a press release from its offices in Pasadena on June 23, 2025.

Who's involved

What this event is mainly about
Arrowhead Pharmaceuticals

Keep exploring

Part of

FDA fast-tracking of a therapy involving Precision BioSciences, Arrowhead Pharmaceuticals, and Gilead Sciences began on July 1, 2025. All 1 developments

The entities involved

Coverage

Newest first; wire copies grouped